Rapid advances in scientific knowledge have resulted in unparalleled opportunities for new discoveries that could substantially improve human health and cure disease. A cadre of scientists who can work at the interface between fundamental science and clinical medicine is essential to accomplish this goal. It is the overarching objective of the Northwestern University Program in Endocrinology, Diabetes and Hormone Action (NUPEDHA) to enable such research in endocrinology, diabetes and metabolism. This objective will be accomplished by training basic and clinical scientists in an environment that integrates rigorous fundamental science into a disease-oriented context. An essential component of this training program is the superb, highly interactive training faculty of 13 outstanding mentors whose research focuses on translational science related to endocrinology, diabetes and metabolism. The faculty group is comprised of a mixture of senior faculty with extensive training experience and younger faculty who are eager to transfer their knowledge and enthusiasm to trainees about to embark upon one of the most exciting stages of their research careers. The overall program objectives are to 1) provide training in the fundamental biology and integrative physiology of endocrinology, diabetes and metabolism in a disease-oriented environment;2) mentor the next generation of investigators who can work at the interface between the laboratory and clinical medicine to ensure that scientific advances are rapidly translated to improve the care of patients with endocrine and metabolic disorders, including diabetes and obesity. The combined training of graduate students, PhDs and Clinical Fellows in Endocrinology and Metabolism emphasizes these objectives as well as the continuum between fundamental science and patient care. The training program contains a core of didactic activities with additional didactic experiences tailored to the needs of each trainee. There are options for training in basic- translational science or clinical research. Trainees in the clinical research pathway are required to enroll in the Northwestern University Masters of Science in Clinical Investigation program. Professional development opportunities include training in manuscript and grant writing, laboratory and project management and pathways to academic success. A rigorous, ongoing program evaluation will be overseen by the Northwestern University Searle Center for Teaching Excellence. NUPEDHA has an outstanding record of accomplishment. Over the past 10 years, NUPEDHA has supported 12 predoctoral trainees and 19 postdoctoral trainees. Sixteen percent of these trainees have been underrepresented minorities. Sixty-three percent of the predoctoral trainees have academic appointments or are in postdoctoral training. Seventy-five percent of the postdoctoral trainees have academic appointments, 50% have independent federal grant support (K99, K23, KL2, K12, Department of Defense) and 25% have appointments in clinician-scholar tracks.

Public Health Relevance

The purpose of this program is to train scientists and physicians who can make scientific discoveries and apply these discoveries to the prevention and treatment of diseases in endocrinology, diabetes and metabolism. Training this scientific workforce is essential for improving human health.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007169-35
Application #
8697039
Study Section
Digestive Diseases and Nutrition C Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1976-07-01
Project End
2016-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
35
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60611
Kim, J; Jin, H; Zhao, J C et al. (2017) FOXA1 inhibits prostate cancer neuroendocrine differentiation. Oncogene 36:4072-4080
Gorsic, Lidija K; Kosova, Gulum; Werstein, Brian et al. (2017) Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome. J Clin Endocrinol Metab 102:2862-2872
Sandler, Victoria; Reisetter, Anna C; Bain, James R et al. (2017) Associations of maternal BMI and insulin resistance with the maternal metabolome and newborn outcomes. Diabetologia 60:518-530
Sam, Susan; Vellanki, Priyathama; Yalamanchi, Sudha K et al. (2017) Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome. Metabolism 71:125-131
Fong, Ka-Wing; Zhao, Jonathan C; Kim, Jung et al. (2017) Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer. Cancer Res 77:412-422
Dapas, Matthew; Kandpal, Manoj; Bi, Yingtao et al. (2017) Comparative evaluation of isoform-level gene expression estimation algorithms for RNA-seq and exon-array platforms. Brief Bioinform 18:260-269
Monsivais, Diana; Dyson, Matthew T; Yin, Ping et al. (2016) Estrogen receptor ? regulates endometriotic cell survival through serum and glucocorticoid-regulated kinase activation. Fertil Steril 105:1266-1273
Ludvik, Anton E; Pusec, Carolina M; Priyadarshini, Medha et al. (2016) HKDC1 Is a Novel Hexokinase Involved in Whole-Body Glucose Use. Endocrinology 157:3452-61
Villa, Stephanie R; Priyadarshini, Medha; Fuller, Miles H et al. (2016) Loss of Free Fatty Acid Receptor 2 leads to impaired islet mass and beta cell survival. Sci Rep 6:28159
Navarro, Guadalupe; Xu, Weiwei; Jacobson, David A et al. (2016) Extranuclear Actions of the Androgen Receptor Enhance Glucose-Stimulated Insulin Secretion in the Male. Cell Metab 23:837-51

Showing the most recent 10 out of 103 publications